Fred Harms

from Wikipedia, the free encyclopedia

Fred Harms (born May 27, 1965 in Wilhelmshaven ) is a German health care researcher .

Career

From 1986 to 1996 he studied bio-chemistry and medicine at the University of Witten / Herdecke , the University of Münster, the MD Anderson Cancer Center, Houston, Teas, USA and the University of Bangkok, with an MD / PhD in tumor immunology / oncology . From 1997 to 1999 he was a lecturer in Innovation Management in Life Sciences at the Technical University of Darmstadt, and from 2000 to 2004 he was a lecturer in Health Care Management at the Technical University of Berlin . From 2005 to 2007 he was a lecturer in Health Care Business Management at the University of Hamburg . From 2008 to 2009 was Scientific Director for Pharmaceutical Business Management at the Center for Management and from 2010 to 2012 Chairman of the Center. He taught as Professor of Healthcare Management at the Mayes College of Healthcare Business and Policy at the University of the Sciences in Philadelphia , USA. Since 2013, he and Dorothee Gänshirt have headed the Institute for Health Communication and Health Services Research (IGV) at the Sigmund Freud University in Vienna .

In addition to his university activities, from 1996 to 2002 he was director of oncology and global project manager at Merck KGaA in Darmstadt and Imclone NY, USA. He was responsible for the development of Erbitux , a chimeric  monoclonal antibody for the treatment of colorectal cancer. From 2002 to 2003 he was Vice President of OncoScore ( Novartis Venture) and consultant of the Tumorbank of the University Clinic Basel, from 2004 to 2014 member of the management of the Health Care Competence Center (HC3) in Basel and since 2016 founder and member of the management of Beneganic Organic Vitamins in Zurich.

Scholarships / Awards

Fred Harms was a scholarship holder of the program for high potentials in life sciences of Hoechst AG Frankfurt from 1997 to 1991 , from 1992 to 1994 scholarship of the study fund of the chemical industry of Henkel AG Düsseldorf, from 2005 to 2006 research scholarship of the Merck, Sharp & Dohme Foundation, Whitehouse Station, NJ. In 2010, together with Dorothee Gänshirt, he received a Letter of Honor from the European Commission in Brussels and in 2012, again with Dorothee Gänshirt, the Certificate of Honor from the International Prevention Organization in Brussels for exceptional scientific achievements in the prevention of vascular diseases.

Research priorities

The Institute for Health Communication and Health Services Research (IGV) at the Sigmund Freud University in Vienna works in cooperation with the European Health Care Foundation (EUHCF) in Zurich on the following areas:

  1. Development of strategies for prevention, compliance and disease management of chronic diseases
  2. Evaluation of the potential benefits of medical innovations for patient care.

The aim of the Institute for Health Communication and Health Services Research and the European Foundation for Health is to develop evidence-based concepts for improved care for people with chronic diseases. One example of this is the patient fox; it is the first self-management portal for chronic diseases in Europe. Another goal is to build a pan-European network of all interest groups in the health system. In cooperation with the European Foundation for Health, the Institute for Health Communication and Health Services Research is creating a platform that catalyzes and promotes the implementation of evaluated health care concepts in Europe.

International memberships

Fred Harms is a member of the following institutions:

  • since 1994 New York Academy of Sciences
  • since 1995 American Association for the Advancement of Science
  • 2001-2005 member of the High-Technology Post-Graduate-Program in Europe (EXIST)
  • since 2003 American Society for Marketing and Management Advances
  • since 2005 Vice President and founding member of the European Health Care Foundation (EUHCF)
  • since 2006 member of the board of the International Prevention Organization (IPO Brussels), from 2012-2014 member of the scientific advisory board of Roche AG (area diabetology )

Fonts (selection)

Harms is the author of around 220 publications, book contributions and lectures at scientific congresses.

  • With Dorothee Gänshirt: Pharma Marketing: Health economic aspects of an innovative industry using the example of Germany, Austria and Switzerland. (Forum Marketing and Management. 4) 2. Completely revised. Berlin: De Gruyter, Oldenburg 2008. ISBN 3-82820429-5
  • With Dorothee Gänshirt: Health marketing: patient empowerment as a core competence . (Forum Marketing and Management. 6.) Berlin: de Gruyter, Oldenburg 2005. ISBN 3-82820317-5

Web links

personal data
SURNAME Harms, Fred
ALTERNATIVE NAMES Harms, F.
BRIEF DESCRIPTION German health care researcher
DATE OF BIRTH May 27, 1965
PLACE OF BIRTH Wilhelmshaven